The Gothenburg breast screening trial

Cancer

Volumn 97, Issue 10, 2003, Pages 2387-2396

  Bjurstam, Nils ^a   Björneld, Lena ^b   Warwick, Jane ^c   Sala, Evis ^d   Duffy, Stephen W ^e   Nyström, Lennarth ^e   Walker, Neil ^f   Cahlin, Erling ^b   Eriksson, Olof ^b   Hafström, Lars Olof ^g   Lingaas, Halvard ^b   Mattsson, Jan ^b   Persson, Stellan ^h   Rudenstam, Carl Magnus ^b   Salander, Håkan ^h   Säve Söderbergh, Johan ^b   Wahlin, Torkel ^h  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e UMEÅ UNIVERSITY   (Sweden)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^h Northern Alvsborg Hospital   (Sweden)

Author keywords

Age specific effects; Breast carcinoma; Mammography screening; Randomized screening trial; Randomized trial

Indexed keywords

ADULT; AGE; ARTICLE; BREAST CARCINOMA; CANCER INCIDENCE; CANCER REGISTRY; CANCER RESEARCH; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; BREAST TUMOR; INCIDENCE; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SURVIVAL; SWEDEN;

ADULT; AGE FACTORS; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; LYMPHATIC METASTASIS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS; SWEDEN;

EID: 0038032765     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11361     Document Type: Article

References (26)

1. Tabár L, Fagerberg G, Duffy SW, Day NE, Gad A, Gröntoft O. Update of the Swedish Two-County Program of mammographic screening for breast cancer. Radiol Clin North Am. 1992;30:187-210.
2. Shapiro S, Venet V, Strax P, Venet L, Roeser R. Selection, follow-up and analysis in the Health Insurance Plan Study: a randomised trial with breast cancer screening. J Natl Cancer Inst Monogr. 1985;67:65-74.
3. Alexander FE, Anderson TJ, Brown HK, et al. The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer. 1994;70:542-548.
4. Frisell J, Lidbrink E, Hellstrom L, Rutqvist LE. Follow-up after 11 years - update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat. 1997;45:263-270.
5. Anderson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ. 1988;297:943-948.
6. Tabár L, Fagerberg G, Chen HH, et al. Efficacy of breast cancer screening by age - new results from the Swedish Two-County Trial. Cancer. 1995;75:2507-2517.
7. Frisell J, Eklund G, Hellstrom L, Lidbrink E, Rutqvist LE, Somell A. Randomized study of mammography screening -preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat. 1991;18:49-56.
8. Shapiro S, Venet W, Strax P, Venet L. Periodic screening for breast cancer: the Health Insurance Plan Project and its sequelae 1963-1986. Baltimore: Johns Hopkins University Press, 1988.
9. Hendrick RE, Smith RA, Rutledge IH, Smart CR. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr. 1997;22:87-92.
10. Organizing Committee and Collaborators. Report of the Organizing Committee and Collaborators, Falun meeting, Falun, Sweden. Breast cancer screening with mammography in women aged 40-49 years. Int J Cancer. 1996;68:693-699.
11. Tabár L, Fagerberg G, Day NE, Holmberg L. What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish Two-County Breast Cancer Screening Trial. Br J Cancer. 1987;55:547-551.
12. Bjurstam N, Björneld L, Duffy SW, et al. The Gothenburg Breast Screening Trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer. 1997;80:2091-2099.
13. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet. 2000;355:129-134.
14. Bjurstam N, Björneld L, Duffy SW, Prevost TC. Re: the Gothenburg Breast Screening Trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer. 1998;83:188-190.
15. Nyström L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359:909-919.
16. Breslow NE, Day NE. Statistical methods in cancer research. 2. The design and analysis of cohort studies. Lyon: IARC Scientific Publications, 1987.
17. Nyström L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: overview of the Swedish randomised trials. Lancet. 1993;341:973-978.
18. Olsen O, Gøtzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet. 2001;358:1340-1342.
19. Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A. Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality, and histology. J Med Screen. 1995; 2:94-98.
20. Alexander FE, Anderson TJ, Brown HK, et al. Fourteen years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet. 1999;353:1903-1908.
21. Berry DA. Benefits and risks of screening mammography for women in their forties: a statistical appraisal. J Natl Cancer Inst. 1998;90:1431-1439.
22. Andersson I, Janzon L. Reduced breast cancer mortality in women under age 50: updated results from the Malmö Mammographic Screening Program. J Natl Cancer Inst Monogr. 1997;22:63-67.
23. UK Trial of Early Detection of Breast Cancer Group. Sixteen-year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer. Lancet. 1999;353:1909-1914.
24. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. Ann Intern Med. 2002;137:305-312.
25. de Koning HJ, Boer R, Warmerdam PG, Beemsterboer PM, van der Maas PJ. Quantitative interpretation of age-specific mortality reduction from the Swedish breast cancer-screening trials. J Natl Cancer Inst. 1995;87:1217-1223.
26. Miller AB, Baines CJ, To T. The Gothenburg Breast Screening Trial: first results on mortality, incidence and mode of detection for women ages 39-49. Cancer. 1998;83:186-188.